<?xml version="1.0" encoding="UTF-8"?>
<p>Additional efficacy endpoints included the change in total GM volume and fat content, GM fibre type and diameter, number of regenerating myofibers, pain, Harris Hip Score and quality of life assessed using the Short Form‚Äê36.</p>
